Glenda Flanagan Buys 6,100 Shares of Vital Farms (NASDAQ:VITL) Stock

Vital Farms, Inc. (NASDAQ:VITL) Director Glenda Flanagan bought 6,100 shares of the company’s stock in a transaction on Monday, May 18th. The shares were bought at an average cost of $8.33 per share, for a total transaction of $50,813.00. Following the transaction, the director directly owned 37,498 shares in the company, valued at approximately $312,358.34. This represents a 19.43% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Vital Farms Stock Down 2.0%

Shares of NASDAQ VITL opened at $9.24 on Friday. The company has a current ratio of 1.77, a quick ratio of 1.00 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $395.93 million, a PE ratio of 8.88 and a beta of 1.20. The stock’s fifty day simple moving average is $12.56 and its two-hundred day simple moving average is $23.53. Vital Farms, Inc. has a 12-month low of $7.95 and a 12-month high of $53.13.

Vital Farms (NASDAQ:VITL) last announced its earnings results on Thursday, May 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.12). The company had revenue of $187.16 million for the quarter, compared to the consensus estimate of $182.40 million. Vital Farms had a net margin of 6.10% and a return on equity of 14.47%. The firm’s revenue was up 15.4% compared to the same quarter last year. During the same period last year, the business posted $0.37 EPS. As a group, analysts expect that Vital Farms, Inc. will post -0.45 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently weighed in on VITL shares. DA Davidson reissued a “neutral” rating and issued a $16.00 price objective (down from $47.00) on shares of Vital Farms in a research report on Monday, May 4th. Stifel Nicolaus reissued a “hold” rating and issued a $10.00 price objective (down from $34.00) on shares of Vital Farms in a research report on Friday, May 8th. William Blair reissued a “market perform” rating on shares of Vital Farms in a research report on Friday, May 8th. Zacks Research cut Vital Farms from a “hold” rating to a “strong sell” rating in a research report on Monday, March 2nd. Finally, Needham & Company LLC lowered their price objective on Vital Farms from $20.00 to $13.00 and set a “buy” rating for the company in a research report on Monday, May 11th. Five research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $27.33.

Trending Headlines about Vital Farms

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Director Glenda Flanagan, director Kofi Owusu Amoo-Gottfried, and other insiders bought shares around the $8.33-$8.92 range, which can signal confidence that Vital Farms is undervalued. Article: Vital Farms insider buying
• Neutral Sentiment: Analysts remain cautious overall, with the stock carrying a consensus “Hold” rating and several recent target cuts, suggesting Wall Street sees limited near-term upside despite the company’s strong revenue growth. Article: Vital Farms rides the pasture-raised egg trend
• Negative Sentiment: Multiple law firms are promoting a class-action lawsuit against Vital Farms tied to alleged disclosure issues during the May 8, 2025 to Feb. 26, 2026 period, and the approaching May 26 lead-plaintiff deadline is keeping legal risk in focus. Article: Investor alert on Vital Farms class action

Hedge Funds Weigh In On Vital Farms

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in VITL. Royal Bank of Canada raised its stake in Vital Farms by 89.2% in the 1st quarter. Royal Bank of Canada now owns 19,381 shares of the company’s stock worth $591,000 after acquiring an additional 9,136 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Vital Farms by 5.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,057 shares of the company’s stock worth $611,000 after acquiring an additional 1,108 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in Vital Farms by 3.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 415,420 shares of the company’s stock worth $12,658,000 after acquiring an additional 13,397 shares during the last quarter. Woodline Partners LP purchased a new position in Vital Farms in the 1st quarter worth $1,073,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Vital Farms by 1.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company’s stock worth $2,739,000 after acquiring an additional 1,198 shares during the last quarter. Hedge funds and other institutional investors own 98.59% of the company’s stock.

About Vital Farms

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.